Table 2. Reported p-values for the STAMPEDE platform trial. SOC = Standard-of-care.

Trial arm	p-value
B: SOC + zoledronic acid	0.450
C: SOC + docetaxel	0.006
E: SOC + zoledronic acid + docetaxel	0.022
D: SOC + celecoxib	0.847
F: SOC + zoledronic acid + celecoxib	0.130
G: SOC + abiraterone	0.001
H: SOC + radiotherapy	0.266